Deputy Director and Associate Director for Clinical Research

Robert Dreicer MD, MS, MACP, FASCO

Robert Dreicer, MD, MS, MACP, FASCO is the Cancer Center’s Deputy Director and Associate Director for Clinical Research, providing administrative and scientific oversight of the Cancer Center’s Office for Clinical Research, the Protocol Review Committee, and the Data and Safety Monitoring Committee. He is also Section Head of Solid Tumor Oncology in the School of Medicine’s Division of Hematology and Oncology, Professor of Medicine and Urology, and Co-Director of the Mellon Institute.

Dr. Dreicer received his medical degree from the University of Texas-Houston and a master of science from the University of Texas Graduate School of Biomedical Sciences at Houston. Following his oncology fellowship, Dreicer joined the faculty at University of Iowa, achieving tenure and serving as the Associate Director of the Division of Hematology/Oncology. He was recruited to Cleveland Clinic, where he served as Chair of the Department of Solid Tumor Oncology from 2006-2014, before joining UVA Cancer Center in 2015.

Dr. Dreicer’s research interests are novel therapeutic approaches for urologic cancers including prostate, urothelial and kidney cancers. He previously served as Co-Chair of the NCI’s Genitourinary Oncology Steering Committee and serves as member of the Medical Oncology Longitudinal Test Assessment Committee of the American Board of Internal Medicine. He has been a longstanding Associate Editor of the New England Journal of Medicine’s Journal Watch Hematology/Oncology.